Société Tunisienne des Maladies Respiratoires et d'Allergologie STMRA - RCT: Novavax vaccine conferred 89.7% protection against symptomatic SARS-CoV-2 infection and 100% protection against hospitalizations or deaths.

Sté Tunisienne des Maladies Respiratoires et d'Allergologie

Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis

RCT: Novavax vaccine conferred 89.7% protection against symptomatic SARS-CoV-2 infection and 100% protection against hospitalizations or deaths.

Zouhair Souissi

Bibliographie

1 juillet 2021

Soyez le premier à commenter!

Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine – New England Journal of Medicine Audio interview: Audio Interview: Another New Covid-19 Vaccine – New England Journal of Medicine Related: Opinion | The mRNA vaccines are extraordinary, but Novavax is even better

The post RCT: Novavax vaccine conferred 89.7% protection against symptomatic SARS-CoV-2 infection and 100% protection against hospitalizations or deaths. appeared first on Links Medicus.

Lu 543 fois